Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Clemens

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
The Biochemical Journal|August 25, 2009
Fluorine substitutions in an antigenic peptide selectively modulate T-cell receptor binding in a minimally perturbing mannerKurt H Piepenbrink, Oleg Y Borbulevych, Ruth F Sommese, et al.
Vaccine|May 14, 2013
Desirability for a typhoid fever vaccine among rural residents, Pemba Island, TanzaniaLinda M Kaljee, Alfred Pach, Kamala Thriemer, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 28, 2017
Use of oral cholera vaccine as a vaccine probe to define the geographical dimensions of person-to-person transmission of choleraMohammad Ali, Deok Ryun Kim, Suman Kanungo, et al.
Vaccine|September 15, 2005
Differences in perception of dysentery and enteric fever and willingness to receive vaccines among rural residents in ChinaXinguang Chen, Bonita Stanton, Xuanyi Wang, et al.
Tropical Medicine & International Health : TM & IH|January 13, 2011
Cost of illness due to typhoid fever in five Asian countriesChristine Poulos, Arthorn Riewpaiboon, John F Stewart, et al.
The Journal of Infectious Diseases|June 8, 2004
Development of pathogenicity-driven definitions of outcomes for a field trial of a killed oral vaccine against enterotoxigenic Escherichia coli in Egypt: application of an evidence-based methodJohn Clemens, Stephen Savarino, Remon Abu-Elyazeed, et al.
Human Vaccines|August 5, 2009
Vaccine desirability during an effectiveness trial of the typhoid fever polysaccharide Vi vaccine in Kolkata IndiaDipika Sur, Byomkesh Manna, Nandini Chakrabarty, et al.
Health Policy and Planning|February 1, 2008
Comparison of cost-of-illness with willingness-to-pay estimates to avoid shigellosis: evidence from ChinaSoyeon Guh, Chen Xingbao, Christine Poulos, et al.
Plos One|June 30, 2015
Diarrheal Illness and Healthcare Seeking Behavior among a Population at High Risk for Diarrhea in Dhaka, BangladeshFahima Chowdhury, Iqbal Ansary Khan, Sweta Patel, et al.
Vaccine|September 13, 2011
Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of ageAmit Saha, Mohiul Islam Chowdhury, Farhana Khanam, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
The Biochemical Journal|August 25, 2009
Fluorine substitutions in an antigenic peptide selectively modulate T-cell receptor binding in a minimally perturbing mannerKurt H Piepenbrink, Oleg Y Borbulevych, Ruth F Sommese, et al.
Vaccine|May 14, 2013
Desirability for a typhoid fever vaccine among rural residents, Pemba Island, TanzaniaLinda M Kaljee, Alfred Pach, Kamala Thriemer, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 28, 2017
Use of oral cholera vaccine as a vaccine probe to define the geographical dimensions of person-to-person transmission of choleraMohammad Ali, Deok Ryun Kim, Suman Kanungo, et al.
Vaccine|September 15, 2005
Differences in perception of dysentery and enteric fever and willingness to receive vaccines among rural residents in ChinaXinguang Chen, Bonita Stanton, Xuanyi Wang, et al.
Tropical Medicine & International Health : TM & IH|January 13, 2011
Cost of illness due to typhoid fever in five Asian countriesChristine Poulos, Arthorn Riewpaiboon, John F Stewart, et al.
The Journal of Infectious Diseases|June 8, 2004
Development of pathogenicity-driven definitions of outcomes for a field trial of a killed oral vaccine against enterotoxigenic Escherichia coli in Egypt: application of an evidence-based methodJohn Clemens, Stephen Savarino, Remon Abu-Elyazeed, et al.
Human Vaccines|August 5, 2009
Vaccine desirability during an effectiveness trial of the typhoid fever polysaccharide Vi vaccine in Kolkata IndiaDipika Sur, Byomkesh Manna, Nandini Chakrabarty, et al.
Health Policy and Planning|February 1, 2008
Comparison of cost-of-illness with willingness-to-pay estimates to avoid shigellosis: evidence from ChinaSoyeon Guh, Chen Xingbao, Christine Poulos, et al.
Plos One|June 30, 2015
Diarrheal Illness and Healthcare Seeking Behavior among a Population at High Risk for Diarrhea in Dhaka, BangladeshFahima Chowdhury, Iqbal Ansary Khan, Sweta Patel, et al.
Vaccine|September 13, 2011
Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of ageAmit Saha, Mohiul Islam Chowdhury, Farhana Khanam, et al.
Pageof 9